サマリー

変形性関節症は炎症性疾患であり、痛みは炎症と密接な関係がある。変形性関節症の鎮痛薬は主に市販薬と処方薬の2種類に分けられる。注射薬、内服薬、外用薬の3種類に大別される。
世界の変形性関節症用鎮痛剤市場は、2023年には100万米ドルに達すると予想され、2022年の100万米ドルと比較すると、%プラスの成長が見込まれています。川下産業からの需要の増加を背景に、変形性関節症鎮痛剤産業は2029年には100万米ドルに達すると評価されています。2023年から2029年までのCAGRは%である。

世界的に、変形性関節症鎮痛剤の主要メーカーには、ファイザー、バイエル、ジョンソン・エンド・ジョンソン、サノフィ、アボット、グラクソ・スミスクライン、TEVA、アルマティカ・ファーマ、アステラス製薬などがあります。ファイザー、バイエル、ジョンソン・エンド・ジョンソンが上位3社であり、2022年の売上シェアは合計で%であった。
消費地域を考慮すると、2022年の変形性関節症鎮痛剤の販売量は、北米、ヨーロッパ、アジア太平洋地域が占める割合が高い。アジア太平洋地域は急成長を遂げ、2023年から2029年までの年平均成長率（CAGR）は%で、2029年の販売シェアは%になると推定される。さらに、中国は変形性関節症の鎮痛剤市場全体において重要な役割を担っており、業界関係者や投資家からさらに注目を集めると推定されます。

変形性関節症鎮痛剤は注射剤、経口剤、外用剤などに分けられる。注射剤は市場の主流製品であり、2022年には世界全体の売上高シェアの％を占め、その割合は2029年には％となる見込みです。
変形性関節症の鎮痛剤は、病院、個人、その他など様々な分野で広く使用されています。病院は変形性関節症鎮痛剤産業の発展を最も支援しています。2022年、世界の変形性関節症鎮痛剤の売上高のうち、病院向けが占める割合は、2029年には%に達するでしょう。

レポートの対象
本レポートは、2018年から2029年までの世界の変形性関節症鎮痛薬市場の概要を紹介し、読者が世界の変形性関節症鎮痛薬市場を多角的に包括的に理解することを目的としています。2018年から2029年までの地域別売上高、収益、2018年から2023年までのメーカーの売上高、価格、収益、粗利益率などの項目を分析しています。さらに、2018年から2029年までの各地域における製品タイプおよび用途の売上高と収益も強調しています。

レポートに掲載されているメーカー、タイプ、アプリケーション、地域
企業別
ジョンソン・エンド・ジョンソン
サノフィ
アボット
グラクソ・スミスクライン
テバ
アルマティカ・ファーマ
アステラス製薬
イロコ製薬
SKケミカルズ
イーライリリー
クリスタルジェノミクス
シナートロ
三笠製薬
第一三共
大正製薬
西濃バイオファーマ
生化学工業
ノバルティス
ホライゾンファーマ
マイラン
アビオジェンファーマ
上海昊海生物技術
浙江成義薬業
江蘇恒瑞医薬
湖南省景峰製薬
北京タイド製薬
江蘇シムセレ製薬
Cspcホールディングス
同心鎮痛薬
タイプ別セグメント
注射薬
経口薬
外用薬
用途別セグメント
病院
個人
その他
地域別セグメント
米国およびカナダ
米国
カナダ
中国
アジア（中国を除く）
日本
韓国
中国 台湾
東南アジア
インド
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
ラテンアメリカ、中東、アフリカ
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

章の概要
第1章：製品の定義、種類、用途の紹介
第2章：2018年から2029年までの地域別収益および販売量分析
第3章：メーカーの変形性関節症鎮痛剤の工場分布、変形性関節症鎮痛剤の商業日、提供される製品タイプ、M&A、拡大活動を含む、メーカーの売上高、収益、価格分析。
第4章：2018年から2029年までの世界のタイプ別製品売上高、収益、価格分析
第5章：2018年から2029年までの世界の用途別製品売上高、収益、価格分析
第6章：米国・カナダにおける2018年から2029年までのタイプ別・用途別製品売上高、収益分析2018年から2029年までの米国＆カナダにおける各国別製品売上高、収益分析
第7章：ヨーロッパにおける2018年から2029年までの製品の販売、タイプ別および用途別収益分析。2018年から2029年までの欧州各国の製品売上高、収益分析
第8章：2018年から2029年までの中国における製品の売上高、タイプ別および用途別の収益分析。2018年から2029年までの中国の製品売上高、収益分析
第9章：2018年から2029年までのアジア（中国を除く）における製品売上高、タイプ別および用途別収益分析。2018年から2029年までのアジア（中国を除く）各国の製品売上高、収益分析
第10章：2018年から2029年までの中東、アフリカ、ラテンアメリカにおける製品の販売、タイプ別および用途別収益分析。2018年から2029年までの中東、アフリカ、ラテンアメリカの各国における製品売上高、収益分析。
第11章：メーカーの概要、企業の基本情報、主要事業、変形性関節症鎮痛薬の紹介などをカバー。2018年から2023年までの各企業の変形性関節症鎮痛薬の売上高、収益、価格、およびグロスマージン
第12章：原材料、製造コストのような産業チェーン分析。市場チャネル、流通業者、顧客分析
第13章：市場機会と課題分析
第14章：変形性関節症鎮痛剤に関するQYResearchの結論
第15章：QYResearchが採用した方法論とデータソース

ページTOPに戻る

目次

1 Study Coverage
1.1 Osteoarthritis Analgesics Product Introduction
1.2 Market by Type
1.2.1 Global Osteoarthritis Analgesics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Injections
1.2.3 Oral Medications
1.2.4 Topical Medications
1.3 Market by Application
1.3.1 Global Osteoarthritis Analgesics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Personal
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Osteoarthritis Analgesics Sales Estimates and Forecasts 2018-2029
2.2 Global Osteoarthritis Analgesics Revenue by Region
2.2.1 Global Osteoarthritis Analgesics Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Osteoarthritis Analgesics Revenue by Region (2018-2023)
2.2.3 Global Osteoarthritis Analgesics Revenue by Region (2024-2029)
2.2.4 Global Osteoarthritis Analgesics Revenue Market Share by Region (2018-2029)
2.3 Global Osteoarthritis Analgesics Sales Estimates and Forecasts 2018-2029
2.4 Global Osteoarthritis Analgesics Sales by Region
2.4.1 Global Osteoarthritis Analgesics Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Osteoarthritis Analgesics Sales by Region (2018-2023)
2.4.3 Global Osteoarthritis Analgesics Sales by Region (2024-2029)
2.4.4 Global Osteoarthritis Analgesics Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Osteoarthritis Analgesics Sales by Manufacturers
3.1.1 Global Osteoarthritis Analgesics Sales by Manufacturers (2018-2023)
3.1.2 Global Osteoarthritis Analgesics Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Osteoarthritis Analgesics in 2022
3.2 Global Osteoarthritis Analgesics Revenue by Manufacturers
3.2.1 Global Osteoarthritis Analgesics Revenue by Manufacturers (2018-2023)
3.2.2 Global Osteoarthritis Analgesics Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Osteoarthritis Analgesics Revenue in 2022
3.3 Global Key Players of Osteoarthritis Analgesics, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Osteoarthritis Analgesics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Osteoarthritis Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Osteoarthritis Analgesics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Osteoarthritis Analgesics, Product Offered and Application
3.8 Global Key Manufacturers of Osteoarthritis Analgesics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Osteoarthritis Analgesics Sales by Type
4.1.1 Global Osteoarthritis Analgesics Historical Sales by Type (2018-2023)
4.1.2 Global Osteoarthritis Analgesics Forecasted Sales by Type (2024-2029)
4.1.3 Global Osteoarthritis Analgesics Sales Market Share by Type (2018-2029)
4.2 Global Osteoarthritis Analgesics Revenue by Type
4.2.1 Global Osteoarthritis Analgesics Historical Revenue by Type (2018-2023)
4.2.2 Global Osteoarthritis Analgesics Forecasted Revenue by Type (2024-2029)
4.2.3 Global Osteoarthritis Analgesics Revenue Market Share by Type (2018-2029)
4.3 Global Osteoarthritis Analgesics Price by Type
4.3.1 Global Osteoarthritis Analgesics Price by Type (2018-2023)
4.3.2 Global Osteoarthritis Analgesics Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Osteoarthritis Analgesics Sales by Application
5.1.1 Global Osteoarthritis Analgesics Historical Sales by Application (2018-2023)
5.1.2 Global Osteoarthritis Analgesics Forecasted Sales by Application (2024-2029)
5.1.3 Global Osteoarthritis Analgesics Sales Market Share by Application (2018-2029)
5.2 Global Osteoarthritis Analgesics Revenue by Application
5.2.1 Global Osteoarthritis Analgesics Historical Revenue by Application (2018-2023)
5.2.2 Global Osteoarthritis Analgesics Forecasted Revenue by Application (2024-2029)
5.2.3 Global Osteoarthritis Analgesics Revenue Market Share by Application (2018-2029)
5.3 Global Osteoarthritis Analgesics Price by Application
5.3.1 Global Osteoarthritis Analgesics Price by Application (2018-2023)
5.3.2 Global Osteoarthritis Analgesics Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Osteoarthritis Analgesics Market Size by Type
6.1.1 US & Canada Osteoarthritis Analgesics Sales by Type (2018-2029)
6.1.2 US & Canada Osteoarthritis Analgesics Revenue by Type (2018-2029)
6.2 US & Canada Osteoarthritis Analgesics Market Size by Application
6.2.1 US & Canada Osteoarthritis Analgesics Sales by Application (2018-2029)
6.2.2 US & Canada Osteoarthritis Analgesics Revenue by Application (2018-2029)
6.3 US & Canada Osteoarthritis Analgesics Market Size by Country
6.3.1 US & Canada Osteoarthritis Analgesics Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Osteoarthritis Analgesics Sales by Country (2018-2029)
6.3.3 US & Canada Osteoarthritis Analgesics Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Osteoarthritis Analgesics Market Size by Type
7.1.1 Europe Osteoarthritis Analgesics Sales by Type (2018-2029)
7.1.2 Europe Osteoarthritis Analgesics Revenue by Type (2018-2029)
7.2 Europe Osteoarthritis Analgesics Market Size by Application
7.2.1 Europe Osteoarthritis Analgesics Sales by Application (2018-2029)
7.2.2 Europe Osteoarthritis Analgesics Revenue by Application (2018-2029)
7.3 Europe Osteoarthritis Analgesics Market Size by Country
7.3.1 Europe Osteoarthritis Analgesics Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Osteoarthritis Analgesics Sales by Country (2018-2029)
7.3.3 Europe Osteoarthritis Analgesics Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Osteoarthritis Analgesics Market Size
8.1.1 China Osteoarthritis Analgesics Sales (2018-2029)
8.1.2 China Osteoarthritis Analgesics Revenue (2018-2029)
8.2 China Osteoarthritis Analgesics Market Size by Application
8.2.1 China Osteoarthritis Analgesics Sales by Application (2018-2029)
8.2.2 China Osteoarthritis Analgesics Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Osteoarthritis Analgesics Market Size by Type
9.1.1 Asia Osteoarthritis Analgesics Sales by Type (2018-2029)
9.1.2 Asia Osteoarthritis Analgesics Revenue by Type (2018-2029)
9.2 Asia Osteoarthritis Analgesics Market Size by Application
9.2.1 Asia Osteoarthritis Analgesics Sales by Application (2018-2029)
9.2.2 Asia Osteoarthritis Analgesics Revenue by Application (2018-2029)
9.3 Asia Osteoarthritis Analgesics Sales by Region
9.3.1 Asia Osteoarthritis Analgesics Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Osteoarthritis Analgesics Revenue by Region (2018-2029)
9.3.3 Asia Osteoarthritis Analgesics Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Osteoarthritis Analgesics Market Size by Type
10.1.1 Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Osteoarthritis Analgesics Market Size by Application
10.2.1 Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Country
10.3.1 Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Osteoarthritis Analgesics Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Osteoarthritis Analgesics Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Pfizer Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Bayer Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Johnson & Johnson Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Sanofi Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 Abbott
11.5.1 Abbott Company Information
11.5.2 Abbott Overview
11.5.3 Abbott Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Abbott Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abbott Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Overview
11.6.3 GlaxoSmithKline Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 GlaxoSmithKline Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Recent Developments
11.7 TEVA
11.7.1 TEVA Company Information
11.7.2 TEVA Overview
11.7.3 TEVA Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 TEVA Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 TEVA Recent Developments
11.8 Almatica Pharma
11.8.1 Almatica Pharma Company Information
11.8.2 Almatica Pharma Overview
11.8.3 Almatica Pharma Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Almatica Pharma Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Almatica Pharma Recent Developments
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Information
11.9.2 Astellas Pharma Overview
11.9.3 Astellas Pharma Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Astellas Pharma Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Astellas Pharma Recent Developments
11.10 Iroko Pharmaceuticals
11.10.1 Iroko Pharmaceuticals Company Information
11.10.2 Iroko Pharmaceuticals Overview
11.10.3 Iroko Pharmaceuticals Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Iroko Pharmaceuticals Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Iroko Pharmaceuticals Recent Developments
11.11 SK Chemicals
11.11.1 SK Chemicals Company Information
11.11.2 SK Chemicals Overview
11.11.3 SK Chemicals Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 SK Chemicals Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 SK Chemicals Recent Developments
11.12 Eli Lilly
11.12.1 Eli Lilly Company Information
11.12.2 Eli Lilly Overview
11.12.3 Eli Lilly Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Eli Lilly Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Eli Lilly Recent Developments
11.13 Crystal Genomics
11.13.1 Crystal Genomics Company Information
11.13.2 Crystal Genomics Overview
11.13.3 Crystal Genomics Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Crystal Genomics Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Crystal Genomics Recent Developments
11.14 Synartro
11.14.1 Synartro Company Information
11.14.2 Synartro Overview
11.14.3 Synartro Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Synartro Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Synartro Recent Developments
11.15 Mikasa Seiyaku
11.15.1 Mikasa Seiyaku Company Information
11.15.2 Mikasa Seiyaku Overview
11.15.3 Mikasa Seiyaku Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Mikasa Seiyaku Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Mikasa Seiyaku Recent Developments
11.16 Daiichi Sankyo
11.16.1 Daiichi Sankyo Company Information
11.16.2 Daiichi Sankyo Overview
11.16.3 Daiichi Sankyo Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Daiichi Sankyo Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Daiichi Sankyo Recent Developments
11.17 Taisho Pharmaceutical
11.17.1 Taisho Pharmaceutical Company Information
11.17.2 Taisho Pharmaceutical Overview
11.17.3 Taisho Pharmaceutical Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Taisho Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Taisho Pharmaceutical Recent Developments
11.18 Sino Biopharmaceutical
11.18.1 Sino Biopharmaceutical Company Information
11.18.2 Sino Biopharmaceutical Overview
11.18.3 Sino Biopharmaceutical Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Sino Biopharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Sino Biopharmaceutical Recent Developments
11.19 Seikagaku
11.19.1 Seikagaku Company Information
11.19.2 Seikagaku Overview
11.19.3 Seikagaku Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.19.4 Seikagaku Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Seikagaku Recent Developments
11.20 Novartis
11.20.1 Novartis Company Information
11.20.2 Novartis Overview
11.20.3 Novartis Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.20.4 Novartis Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Novartis Recent Developments
11.21 Horizon Pharma
11.21.1 Horizon Pharma Company Information
11.21.2 Horizon Pharma Overview
11.21.3 Horizon Pharma Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.21.4 Horizon Pharma Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Horizon Pharma Recent Developments
11.22 Mylan
11.22.1 Mylan Company Information
11.22.2 Mylan Overview
11.22.3 Mylan Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.22.4 Mylan Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Mylan Recent Developments
11.23 Abiogen Pharma
11.23.1 Abiogen Pharma Company Information
11.23.2 Abiogen Pharma Overview
11.23.3 Abiogen Pharma Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.23.4 Abiogen Pharma Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Abiogen Pharma Recent Developments
11.24 Shanghai Haohai Biological Technology
11.24.1 Shanghai Haohai Biological Technology Company Information
11.24.2 Shanghai Haohai Biological Technology Overview
11.24.3 Shanghai Haohai Biological Technology Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.24.4 Shanghai Haohai Biological Technology Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Shanghai Haohai Biological Technology Recent Developments
11.25 Zhejiang ChengYi Pharmaceutical
11.25.1 Zhejiang ChengYi Pharmaceutical Company Information
11.25.2 Zhejiang ChengYi Pharmaceutical Overview
11.25.3 Zhejiang ChengYi Pharmaceutical Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.25.4 Zhejiang ChengYi Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Zhejiang ChengYi Pharmaceutical Recent Developments
11.26 Jiangsu Hengrui Medicine
11.26.1 Jiangsu Hengrui Medicine Company Information
11.26.2 Jiangsu Hengrui Medicine Overview
11.26.3 Jiangsu Hengrui Medicine Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.26.4 Jiangsu Hengrui Medicine Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 Jiangsu Hengrui Medicine Recent Developments
11.27 Hunan Jingfeng Pharmaceutical
11.27.1 Hunan Jingfeng Pharmaceutical Company Information
11.27.2 Hunan Jingfeng Pharmaceutical Overview
11.27.3 Hunan Jingfeng Pharmaceutical Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.27.4 Hunan Jingfeng Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.27.5 Hunan Jingfeng Pharmaceutical Recent Developments
11.28 Beijing Tide Pharmaceutical
11.28.1 Beijing Tide Pharmaceutical Company Information
11.28.2 Beijing Tide Pharmaceutical Overview
11.28.3 Beijing Tide Pharmaceutical Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.28.4 Beijing Tide Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.28.5 Beijing Tide Pharmaceutical Recent Developments
11.29 Jiangsu Simcere Pharmaceutical
11.29.1 Jiangsu Simcere Pharmaceutical Company Information
11.29.2 Jiangsu Simcere Pharmaceutical Overview
11.29.3 Jiangsu Simcere Pharmaceutical Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.29.4 Jiangsu Simcere Pharmaceutical Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.29.5 Jiangsu Simcere Pharmaceutical Recent Developments
11.30 Cspc Holdings
11.30.1 Cspc Holdings Company Information
11.30.2 Cspc Holdings Overview
11.30.3 Cspc Holdings Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.30.4 Cspc Holdings Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.30.5 Cspc Holdings Recent Developments
11.31 Concentric Analgesics
11.31.1 Concentric Analgesics Company Information
11.31.2 Concentric Analgesics Overview
11.31.3 Concentric Analgesics Osteoarthritis Analgesics Sales, Price, Revenue and Gross Margin (2018-2023)
11.31.4 Concentric Analgesics Osteoarthritis Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.31.5 Concentric Analgesics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Osteoarthritis Analgesics Industry Chain Analysis
12.2 Osteoarthritis Analgesics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Osteoarthritis Analgesics Production Mode & Process
12.4 Osteoarthritis Analgesics Sales and Marketing
12.4.1 Osteoarthritis Analgesics Sales Channels
12.4.2 Osteoarthritis Analgesics Distributors
12.5 Osteoarthritis Analgesics Customers
13 Market Dynamics
13.1 Osteoarthritis Analgesics Industry Trends
13.2 Osteoarthritis Analgesics Market Drivers
13.3 Osteoarthritis Analgesics Market Challenges
13.4 Osteoarthritis Analgesics Market Restraints
14 Key Findings in The Global Osteoarthritis Analgesics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer